References
- TYılmaz, GGedikoğlu, AÇelik, MÖnerci, ETuran. Prognostic significance of Langerhans cell infiltration in cancer of the larynx. Otolaryngol Head Neck Surg 2005;132:309–16.
- TYılmaz, GGedikoğlu, BGürsel. The relationship between tumor thickness and clinical and histopathologic parameters in cancer of the larynx. Otolaryngol Head Neck Surg 2003;129:192–8.
- TYılmaz, ETuran, BGürsel, MÖnerci, SKaya. Positive surgical margins in cancer of the larynx. Eur Arch Otorhinolaryngol 2001;258:188–91.
- TYılmaz, ETuran, ASHoşal, SKaya. Comparison of regional recurrence rates of radical and comprehensive neck dissection type 3 in N0 laryngeal cancer. Otolaryngol Head Neck Surg 2000;122:736–8.
- ENMyers, AAlvi. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope 1996;106:559–67.
- PCWeber, JTJohnson, ENMyers. The impact of bilateral neck dissection on pattern of recurrence and survival in supraglottic carcinoma. Arch Otolaryngol Head Neck Surg 1994;120:703–6.
- WLHicksJr, DRKollmorgen, MAKuriakose, JOrner, VYBakamjian, JWinston, et al. Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg 1999;121:57–61.
- TEAlpert, SMorbidini-Gaffney, CTChung, JABogart, SSHahn, JHsu, et al. Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer. Cancer J 2004;10:335–8.
- JKGoudakos, KMarkou, ANikolaou, CThemelis, VVital. Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: a systematic review. Eur J Surg Oncol 2009;35:223–9.
- CSuárez, JLLlorente, FNuñez, CDiaz, JGomez. Neck dissection with or without postoperative radiotherapy in supraglottic carcinomas. Otolaryngol Head Neck Surg 1993;109:3–9.
- HHRamadan, GCAllen. The influence of elective neck dissection on neck relapse in N0 supraglottic carcinoma. Am J Otolaryngol 1993;14:278–81.
- GPeretti, CPiazza, MAnsarin, LDe Benedetto, DCocco, ACattaneo, et al. Transoral CO2 laser microsurgery for Tis-T3 supraglottic squamous cell carcinomas. Eur Arch Otorhinolaryngol 2010;267:1735–42.
- AAmar, HMChedid, SAFranzi, ARapoport. Neck dissection in squamous cell carcinoma of the larynx: indication of elective contralateral neck dissection. Braz J Otorhinolaryngol 2012;78:7–10.
- SOztürkcan, HKatilmiş, IOzdemir, BTuna, IAGüvenç, RDündar. Occult contralateral nodal metastases in supraglottic laryngeal cancer crossing the midline. Eur Arch Otorhinolaryngol 2009;266:117–20.
- SÇağli, IYüce, OGYiğitbaşı, EGüney. Is routine bilateral neck dissection absolutely necessary in the management of N0 neck in patients with supraglottic carcinoma? Eur Arch Otorhinolaryngol 2007;264:1453–7.
- LIAmorós Sebastiá, MCarrasco Llatas, CLópez Mollá, APlá Mocholí, MJFerrer Ramírez, JEEstelles Ferriol, et al. Treatment of the N0 neck in supraglottic cancer. Acta Otorrinolaringol Esp 2003;54:577–83.
- LORedaelli de Zinis, PNicolai, DTomenzoli, DGhizzardi, MTrimarchi, JCappiello, et al. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Head Neck 2002;24:913–20.
- OGallo, IFini-Storchi, LNapolitano. Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1-3). Head Neck 2000;22:386–92.
- LORedaelli de Zinis, PNicolai, MGBarezzani, DTomenzoli, ARAntonelli. Incidence and distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Acta Otorhinolaryngol Ital 1994;14:19–27.
- RTGregor, SSOei, FJHilgers, AAHart, AJBalm, RBKeus. Management of cervical metastases in supraglottic cancer. Ann Otol Rhinol Laryngol 1996;105:845–50.